Related content

Effect of Fluoxetine on the Pharmacokinetics of Lansoprazole: A Two-Treatment Period Study in Healthy Male Subjects

By Vlase Laurian  

Clinical Drug Investigation, Vol. 31, Iss. 10, 2011-10 ,pp. : 727-733

Adis International

Access to resources Recommend Favorite

The effect of CYP2C19 activity on pharmacokinetics of lansoprazole and its active metabolites in healthy subjects

By Xu Hong-Rong   Chen Wei-Li   Li Xue-Ning   Chu Nan-Nan  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 48, Iss. 8, 2010-08 ,pp. : 947-952

Informa Healthcare

Access to resources Recommend Favorite

Effect of a selective CYP2C9 inhibitor on the pharmacokinetics of nateglinide in healthy subjects

By Sabia Helene   Sunkara Gangadhar   Ligueros-Saylan Monica   Wang Yibin   Smith Harold   McLeod James   Prasad Pratapa  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 6, 2004-09 ,pp. : 407-412

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects

By Stangier Joachim  

Clinical Pharmacokinetics, Vol. 47, Iss. 1, 2008-01 ,pp. : 47-59

Adis International

Access to resources Recommend Favorite

Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 3, 2015-03 ,pp. : 226-236

John Wiley & Sons Inc

Access to resources Recommend Favorite